Disease In Companion Animals Research Articles

Epithelial barrier dysfunction and associated diseases in companion animals: Differences and similarities between humans and animals and research needs.

Since the 1960s, more than 350,000 new chemicals have been introduced into the lives of humans and domestic animals. Many of them have become part of modern life and some are affecting nature as pollutants. Yet, our comprehension of their potential health risks for both humans and animals remains partial. The "epithelial barrier theory" suggests that genetic predisposition and exposure to diverse factors damaging the epithelial barriers contribute to the emergence of allergic and autoimmune conditions. Impaired epithelial barriers, microbial dysbiosis, and tissue inflammation have been observed in a high number of mucosal inflammatory, autoimmune and neuropsychiatric diseases, many of which showed increased prevalence in the last decades. Pets, especially cats and dogs, share living spaces with humans and are exposed to household cleaners, personal care products, air pollutants, and microplastics. The utilisation of cosmetic products and food additives for pets is on the rise, unfortunately, accompanied by less rigorous safety regulations than those governing human products. In this review, we explore the implications of disruptions in epithelial barriers on the well-being of companion animals, drawing comparisons with humans, and endeavour to elucidate the spectrum of diseases that afflict them. In addition, future research areas with the interconnectedness of human, animal, and environmental well-being are highlighted in line with the "One Health" concept.

12525 Feline Hypersomatotropism In The USA And Canada: Demographics Of 4620 Cats With Presumed Acromegaly

Abstract Disclosure: R.J. Egbert: None. R.C. Fowkes: None. S.J. Niessen: None. B.K. Petroff: None. Spontaneous models of endocrinopathies are powerful tools to understand disease etiology. Endocrine diseases in companion animals are particularly useful to study, as they share their environment with humans and typically present with clinical disease that phenocopies human symptoms. One such disease in domestic cats, hypersomatotropism (HST, feline acromegaly), is a disorder of excessive growth hormone and increased IGF-1 (Insulin like Growth Factor 1), usually caused by hyperplasia or neuroendocrine tumors of the pars distalis of the pituitary gland. This retrospective study used serum IGF-1 results to investigate population characteristics for domestic cats with HST in the United States and Canada. Laboratory records from 1Jan06 to 31Dec22 were reviewed and animals with a circulating IGF-1 hormone concentration of 190 nmol/L (1,450 ng/mL) or greater were presumed to have acromegaly. This review identified 4,620 such cats with a mean age (n=4,351) of 11.2 years (median: 11.2, range: .5-20.3yr) and mean weight (n=2,086) of 6.03 Kg (median: 5.91, range: 2.27-15.0 Kg). Males outnumbered females in the database, which included 3,048 males and 1,181 females. Domestic Short/Medium/Longhair cats were the most prevalent breed (n=3,563; 77%), followed by Maine Coon cats (n=120; 2.6%) and Siamese cats (n=111, 2.4%). Just under half of the animals (n=2,037, 44%) had a history of diabetes mellitus on the submission form. Most submissions were from the US (n=4,347, 94%) with the most hypersomatotropic cats from California (n=841, 18.2%), New York (n=604, 13.1%), Massachusetts (n=402, 8.7%), Colorado (225, 4.9%), and Texas (200, 4.3%). The mean serum IGF-1 concentration of these animals was 358 nmol/mL (median: 345, range 190-761 nmol/mL). For comparison, an age and sex matched control group of 95 animals with residual samples previously submitted for unrelated testing was selected. The mean IGF-1 concentration for the control group was 97 nmol/mL (median: 85, range 0-311 nmol/mL). In summary, HST is diagnosed most frequently in older male cats in urbanized North America, and potentially displays some breed disposition, suggesting both a genetic and environmental component to the disease etiology. Presentation: 6/2/2024

Molecular screening of selected vector-borne pathogens circulating in owned dogs in the Caribbean archipelago of Guadeloupe (France)

Vector-borne diseases represent a major health challenge, both because of the complexity of their control, their common zoonotic nature, or the pathology they can cause in the individual. In tropical areas, surveillance of these diseases is even more important, since the activity of vectors is usually continuous throughout the year. To develop effective prophylaxis and surveillance programs, it is important to know the identity and prevalence of these pathogens as well as their distribution in a given territory. In Guadeloupe, a French archipelago located in the Lesser Antilles of the Caribbean, no information exists about vector-borne diseases in companion animals. With this aim, blood samples were obtained from 46 owned dogs with outdoor access from five different veterinary clinics located in the two mainland islands, and the presence of DNA of the main canine vector-borne pathogens (CVBP) was investigated through diverse PCR protocols. At least one pathogen was detected in 30.4 % of the dogs. The most frequently detected CVBP was Coxiella burnetii (17.4 %), followed by Dirofilaria immitis (8.7 %), and Candidatus Mycoplasma haematoparvum, Hepatozoon canis and Rickettsia spp. (2.2 % in all cases). One dog was coinfected with Candidatus M. haematoparvum and D. immitis. All samples were negative for Anaplasma spp., Ehrlichia spp., Bartonella spp., Borrelia burgdorferi sensu lato, piroplasmids, and Leishmania spp. No significant differences in pathogen occurrence were observed between the two main islands or according to the dog's sex and age groups. This study contributes to filling a relevant gap in the knowledge of vector-borne diseases in the Caribbean.

Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research

Chemoprophylactic prevention of veterinary heartworm disease in companion animals, caused by the vector-borne nematode parasite Dirofilaria immitis, is a multi-billion-dollar global market. Experimental use of cats and dogs in preclinical heartworm drug testing is increasing due to evolving drug-resistance to frontline macrocyclic lactones and renewed investment in alternative preventative drug research. We and others recently published data demonstrating proof-of-concept of utilising lymphopenic severe-combined immunodeficient (SCID) or Recombination Activating Gene (RAG)2 deficient mice with additional knockout of the IL-2/7 receptor gamma chain (γc) as alternative preventative drug screening research models of dirofilariasis. Here we summarise the current knowledge of candidate immunodeficient mouse models tested, including a comparison of susceptibility using different background strains of mice, different D. immitis isolates, following use of anti-inflammatory treatments to further suppress residual innate immunity, and efficacies achieved against different reference anthelmintics. We supplement this precis with new data on treatment response to the veterinary anthelmintic, oxfendazole, and initial evaluation of D. immitis susceptibility in CB.17 SCID and C57BL/6 RAG2-/-γc-/- mice. We conclude that in addition to NSG and NXG mice, RAG2-/-γc-/- mice on either a BALB/c or C57BL/6 background offer an alternative screening model option, widening access to academic and commercial laboratories wishing to pursue initial rapid in vivo drug screening whilst avoiding potentially unnecessary cat or dog testing.

Role of fimbriae variations in Porphyromonas gulae biofilm formation

ObjectivesPorphyromonas gulae is a major causative agent of periodontal disease in companion animals that possesses various virulence factors, including fimbriae, lipopolysaccharides, and proteases. P. gulae fimbriae are classified into three genotypes (A, B, and C) based on their nucleotide sequences. Type C fimbrial isolates have been reported to be more virulent than other fimA types, suggesting that different fimA types may aid in the regulation of periodontal pathogenesis. Detailed findings regarding the ability of P. gulae to form biofilms have yet to be reported. Here, we investigated the contributions of fimbrial genotypes in P. gulae biofilm formation. MethodsP. gulae and P. gingivalis biofilms were generated on plates and analyzed using confocal laser microscopy. Additionally, the biofilms formed were assessed by staining with crystal violet. Furthermore, the physical strength of P. gulae biofilms was examined by ultrasonication. ResultsBiofilms formed by P. gulae type C were denser than those formed by types A and B. Moreover, the amount of biofilm formed by type C strains was significantly greater than that formed by type A and B strains, which was similar to the biofilms formed by P. gingivalis with type II fimbriae. Additionally, the physical strength of the type C biofilm was significantly greater than that of the other strains. ConclusionsThese results suggest that FimA variation may coordinate for biofilm formation. This is the first report on the observation and characterization of P. gulae biofilm formation.

Clinical applications of in vivo confocal microscopy enhance the detection and management of ocular surface disease in dogs and cats.

In vivo confocal microscopy (IVCM) is a unique imaging technique that permits noninvasive evaluation of the ocular surface on the cellular level. High-resolution images of all layers of the cornea are obtained in real-time with IVCM, and the acquired images are often comparable to ex vivo histochemical analysis of corneal biopsy specimens. The basic morphological features of the healthy living cornea as viewed by IVCM are reported in many domestic animal species, and the number of published descriptions of ocular surface pathologies in companion animals is progressively expanding. There is great potential for IVCM to improve the detection, characterization, and management of diverse ocular surface diseases in companion animals. This review summarizes several established and emerging clinical applications of IVCM in companion animal ocular surface disease, including infectious keratitis, corneal foreign bodies, corneal dystrophies and degenerations, ocular surface masses, corneal endotheliitis, pigmentary keratitis, and evaluation of corneal nerves.

The Transmission of SARS-CoV-2 from COVID-19-Diagnosed People to Their Pet Dogs and Cats in a Multi-Year Surveillance Project.

Recent emerging zoonotic disease outbreaks, such as that of SARS-CoV-2, have demonstrated the need for wider companion animal disease surveillance. We tested 1000 dogs and cats belonging to employees of a US veterinary hospital network that were exposed to human COVID-19 cases in the household between 1 January 2020 and 10 March 2022 for SARS-CoV-2 and surveyed their owners about clinical signs and risk factors. The seropositivity was 33% for 747 dogs and 27% for 253 cats. Pet seropositivity correlated with the US human case rates over time, exhibiting peaks corresponding with the major COVID-19 surges. Antibodies persisted longer than previously documented (828 days in dogs; 650 days in cats). Increasing age and duration of proximity to infected people were associated with increased seropositivity in dogs but not cats. Cats were more likely to have clinical signs, but an association between seropositivity and the presence of clinical signs was not found in either species.

COVID-19 restrictions limit the circulation of H3N2 canine influenza virus in China

Canine health is consistently affected by the circulation of the H3N2 strain of canine influenza virus (CIV). Prior research has indicated that the isolation rate of H3N2 CIVs in dogs has gradually increased in China, and these viruses have progressively adapted to humans over the course of their evolution within canine hosts, posing a significant public health threat. However, the key factors influencing the spread of CIVs remain elusive. From January 2020 to December 2022, during the COVID-19 pandemic, strict epidemic prevention policies were implemented in China. Thus, this measure provides an ideal model for studying factors influencing the prevalence of CIVs. In this study, we continuously monitored the prevalence of CIVs in China before and after the COVID-19 pandemic. We found that the pathogen detection rate and seropositivity rate of domestic CIVs significantly declined after the implementation of epidemic control measures. However, after restrictions on human movement were lifted in 2023, the circulation of CIVs gradually increased. Our results demonstrate that restricting human activity directly impacts the epidemic caused by CIVs and provide a theoretical basis for the implementation of control measures during outbreaks of zoonotic diseases in human companion animals.

Evaluation of stem-cell therapies in companion animal disease models: a concise review (2015-2023).

Companion animals in veterinary medicine develop multiple naturally occurring diseases analogous to human conditions. We previously reported a comprehensive review on the feasibility, safety, and biologic activity of using novel stem cell therapies to treat a variety of inflammatory conditions in dogs and cats (2008-2015) [Hoffman AM, Dow SW. Concise review: stem cell trials using companion animal disease models. Stem Cells. 2016;34(7):1709-1729. https://doi.org/10.1002/stem.2377]. The purpose of this review is to provide an updated summary of current studies in companion animal disease models that have evaluated stem cell therapeutics that are relevant to human disease. Here we have reviewed the literature from 2015 to 2023 for publications on stem cell therapies that have been evaluated in companion animals, including dogs, cats, and horses. The review excluded case reports or studies performed in experimentally induced models of disease, studies involving cancer, or studies in purpose-bred laboratory species such as rodents. We identified 45 manuscripts meeting these criteria, an increase from 19 that were described in the previous review [Hoffman AM, Dow SW. Concise review: stem cell trials using companion animal disease models. Stem Cells. 2016;34(7):1709-1729. https://doi.org/10.1002/stem.2377]. The majority of studies were performed in dogs (n = 28), with additional studies in horses (n = 9) and cats (n = 8). Disease models included those related to musculoskeletal disease (osteoarthritis and tendon/ligament injury), neurologic disease (canine cognitive dysfunction, intervertebral disc disease, spinal cord injury) gingival/dental disease (gingivostomatitis), dermatologic disease (atopic dermatitis), chronic multi-drug resistant infections, ophthalmic disease (keratoconjunctivitis sicca, eosinophilic keratitis, immune-mediated keratitis), cardiopulmonary disease (asthma, degenerative valve disease, dilated cardiomyopathy), gastrointestinal disease (inflammatory bowel disease, chronic enteropathy), and renal disease (chronic kidney disease). The majority of studies reported beneficial responses to stem cell treatment, with the exception of those related to more chronic processes such as spinal cord injury and chronic kidney disease. However, it should also be noted that 22 studies were open-label, baseline-controlled trials and only 12 studies were randomized and controlled, making overall study interpretation difficult. As noted in the previous review, improved regulatory oversight and consistency in manufacturing of stem cell therapies are needed. Enhanced understanding of the temporal course of disease processes using advanced-omics approaches may further inform mechanisms of action and help define appropriate timing of interventions. Future directions of stem-cell-based therapies could include use of stem-cell-derived extracellular vesicles, or cell conditioning approaches to direct cells to specific pathways that are tailored to individual disease processes and stages of illness.

Current status of immunodeficient mouse models as substitutes to reduce cat and dog use in heartworm preclinical research.

Chemoprophylactic prevention of veterinary heartworm disease in companion animals, caused by the vector-borne nematode parasite Dirofilaria immitis, is a multi-billion-dollar global market. Experimental use of cats and dogs in preclinical heartworm drug testing is increasing due to evolving drug-resistance to frontline macrocyclic lactones and renewed investment in alternative preventative drug research. We and others recently published data demonstrating proof-of-concept of utilising lymphopenic severe-combined immunodeficient (SCID) or Recombination Activating Gene (RAG)2 deficient mice with additional knockout of the IL-2/7 receptor gamma chain (γc) as alternative preventative drug screening research models of dirofilariasis. Here we summarise the current knowledge of candidate immunodeficient mouse models tested, including a comparison of susceptibility using different background strains of mice, different D. immitis isolates, following use of anti-inflammatory treatments to further suppress residual innate immunity, and efficacies achieved against different reference anthelmintics. We supplement this precis with new data on treatment response to the veterinary anthelmintic, oxfendazole, and initial evaluation of D. immitis susceptibility in CB.17 SCID and C57BL/6 RAG2 -/-γc -/- mice. We conclude that in addition to NSG and NXG mice, RAG2 -/-γc -/- mice on either a BALB/c or C57BL/6 background offer an alternative screening model option, widening access to academic and commercial laboratories wishing to pursue initial rapid in vivo drug screening whilst avoiding potentially unnecessary cat or dog testing.

Current Advances in Mesenchymal Stem Cell Therapies Applied to Wounds and Skin, Eye, and Neuromuscular Diseases in Companion Animals.

Mesenchymal stem cells (MSCs) are considered a very promising alternative tool in cell therapies and regenerative medicine due to their ease of obtaining from various tissues and their ability to differentiate into different cell types. This manuscript provides a review of current knowledge on the use of MSC-based therapies as an alternative for certain common pathologies in dogs and cats where conventional treatments are ineffective. The aim of this review is to assist clinical veterinarians in making decisions about the suitability of each protocol from a clinical perspective, rather than focusing solely on research. MSC-based therapies have shown promising results in certain pathologies, such as spinal cord injuries, wounds, and skin and eye diseases. However, the effectiveness of these cell therapies can be influenced by a wide array of factors, leading to varying outcomes. Future research will focus on designing protocols and methodologies that allow more precise and effective MSC treatments for each case.

반려동물의 장내 마이크로바이옴과 약물의 상호 작용; 중개연구 관점

Drug responses are showed in individual variability. It can be main causes of adverse drug reactions or extended therapies, which result in burden of substantial health. Despite of extensive investigation in pharmacogenomics in terms of the impact of individual genetics on drug-metabolism, a limited proportion of drug-individual variability explains genetic diversity. The gut microbiota and its metabolites have been proven a role to modulate therapeutic outcomes in diseases. Therefore, in this article, we present the interaction between microbiota and drug responses in companion animal diseases, including cancer, endocrine diseases, and others. Also, we summarize how microbiota modify metabolism and distribution of drugs. The practical challenges and opportunities are also discussed in this new field, emphasizing the needs to translate human data into clinical veterinary practice. In summary pharmacomicrobiomics, the interaction between gut microbiota and drug response, may be a promising research field to improve the outcomes of drug effects in patients.

Effectiveness of modern antiparasitic animal collars

Despite the successes achieved in the prevention and control of parasitic diseases in companion animals, the issue of developing and implementing innovative, highly effective antiparasitic agents in veterinary practice is still relevant today. This study aimed to evaluate the efficacy of modern antiparasitic collars for dogs and cats in the prevention and treatment of ectoparasitic infections. The antiparasitic agents used in the experiments were ‘Flea and tick collar Comfort for cats’, ‘Antiparasitic collar TM Healthy Pet, Oberig’, ‘Flea and tick collar Comfort for dogs’, and ‘Antiparasitic collar TM Compliment, Oberig’. The active ingredient in the collars tested is diazinon. The experimental studies were conducted under current methodological recommendations and practical guidelines. The study of shelter pets and stray animals revealed their infestation with lice, fleas, and parasitic ticks of varying intensity. Experimentally, a high insecticidal effect of the products ‘Flea and tick collar Comfort for cats’ and ‘Antiparasitic collar TM Healthy Pet, Oberig’ was established, ‘Flea and tick collar Comfort for dogs’, ‘Antiparasitic collar TM Compliment, Oberig’ against fleas (Ctenocephalides felis, Ctenocephalides canis), chewing lice (Felicola subrostratus), sucking lice (Linognathus setosus), ticks (Ixodes ricinus, Dermacentor spp., Rhipicephalus spp.) The effectiveness of the drugs is 100%. It has been experimentally proven that the studied collars with the active ingredient diazinon can be used for preventive and therapeutic purposes for companion animals in case of infestation with fleas, chewing lice, sucking lice, and ticks

The effect of dietary olive polyphenols on markers of inflammation and bodyweight in senior domestic cats

Abstract The high rates of obesity and degenerative joint disease in companion animals has resulted in a demand for dietary supplements that support joint health and reduce inflammation. Polyphenols have received considerable attention in this space, although literature in companion animals is lacking or conflicting. This study determined whether a diet supplemented with olive polyphenol extract had the potential to reduce inflammation and/or bodyweight. Eight senior domestic cats aged 11.01 ± 0.74 years (mean ± standard error of the mean) and weighing 3.6 ± 0.3 kg (mean ± SEM) were used for this study. The cats were fed, ad libitum with a complete (AAFCO) canned diet supplemented with 0.1% olive polyphenol extract for 56 days. Cats were weighed weekly and blood samples taken on day 0 (baseline), 28, and 56 of the study. Biochemistry, haematology, and cytokine (19 cytokines or chemokines) panels were run for each blood sample. While there was an initial aversion to the supplemented diet, intakes of the cats increased, and they consumed enough to meet or exceed their daily maintenance energy requirements by day 10 of the trial. On average, the cats lost approximately 8% of their starting weight over the trial, which was interesting given that feed intake exceeding maintenance energy requirements for most of the study. Whether the decrease in bodyweight was due to seasonal changes, the supplemented diet, or a combination of the two warrants further investigation. There were little to no changes to any of the blood parameters, which was surprising given that previous studies have reported reductions in pro-inflammatory cytokines following polyphenol supplementation. Perhaps a higher concentration of olive polyphenols is required to elicit the anti-inflammatory response observed in other species. A study evaluating the dose-dependent effects of dietary polyphenols on inflammatory and oxidative markers in cats would be valuable in this context.

Monitoring of microflora in case of infectious pathology in dogs and cats

Infectious agents in the environment, favorable conditions, transmission factors, and a weakened animal body lead to an infectious process. Infectious diseases can affect humans and animals equally, so preventing and eliminating pathogenic agents is essential. Moreover, there is a threat of resistance development among pathogens and their spread. This problem is caused by the irrational use of antibacterial drugs for therapeutic purposes, the duration of treatment, and their frequent use. Given that an animal can be a source of infection for humans, there is a risk of transmission of antibiotic-resistant bacterial strains from animal to human. In order to prevent the resistance of microorganisms to antibacterial agents, there is a pharmacodynamic justification for drug dosage regimens and microbiological studies to control the spread of infectious diseases and pathogens that cause disease. The purpose of our research was to monitor infectious pathologies in dogs and cats in the city of Bila Tserkva, to isolate and identify isolates from samples from three veterinary clinics (“Veterinary assistance”, 44 Shalom-Aleichem St.; “Interdepartmental Clinic of Small Pets of the Bila Tserkva NAU”, 126 Stavyshchanska St.; “Veterinary assistance”, 38 Korolenko St.). The test material was sent to the Educational and Scientific Laboratory of Molecular Diagnostics of Bila Tserkva NAU. According to the VebForce system statistics, the most common diseases in companion animals among the clinic's patients were plyometrics, otitis media, abscesses, and wounds (of various origins). The results of microbiological monitoring for the period from January 1, 2022, to January 1, 2023, show that the study of infected material in purulent and inflammatory processes revealed a wide variety of isolates. The pyometrics in cats were predominantly used: Staphylococcus aureus, Escherichia coli, and Staphylococcus epidermidis. In bitches, Escherichia coli, Staphylococcus spp., Streptococcus canis were mainly isolated. The following isolates were found in the study of wound microflora (of different origin): in cats – Staphylococcus epidermidis, Escherichia coli, Staphylococcus aureus; in dogs – Staphylococcus spp., S. pseudintermedius, Streptococcus spp. In the study of animals with otitis media – Escherichia coli and Staphylococcus epidermidis were mainly found in cats, and Streptococcus spp. and Staphylococcus spp. were mainly isolated from dog abscesses: Escherichia coli; Staphylococcus epidermidis, in dogs – S. epidermidis and Escherichia coli. Today, infectious pathologies are an urgent problem often found in companion animals.

Minimal clinically-important differences for the "Liverpool Osteoarthritis in Dogs" (LOAD) and the "Canine Orthopedic Index" (COI) in dogs with osteoarthritis.

Osteoarthritis is the most common joint disease in companion animals. Several client-report outcome measures (CROMs) have been developed and validated to monitor patients and their response to treatment. However, estimates for minimal clinically-important differences for these CROMs in the context of osteoarthritis have not been published. Data from the Clínica Veterinária de Cães (Portuguese Gendarmerie Canine Clinic) clinical records were extracted. Baseline and 30-day post-treatment follow-up data from 296 dogs treated for hip osteoarthritis were categorized based on an anchor question, and estimates of minimal clinically-important differences (MCIDs) using distribution-based and anchor-based methods were performed. For the LOAD, the anchor-based methods provided a MCID estimate range of -2.5 to -9.1 and the distribution-based methods from 1.6 to 4.2. For the COI, the anchor-based methods provided a MCID estimate range of -4.5 to -16.6 and the distribution-based methods from 2.3 to 2.4. For the dimensions of COI, values varied from -0.5 to -4.9 with the anchor-based methods and from 0.6 to 2.7 with the distribution-based methods. Receiver operator characteristic curves provided areas under the curve >0.7 for the COI, indicating an acceptable cut-off point, and >0.8 for the LOAD, indicating an excellent cut-off point. Our estimates of MCIDs for dogs with OA were consistent with previously proposed values of -4 for the LOAD and -14 for the COI in a post-surgical intervention context. ROC curve data suggest that LOAD may more reliably differentiate between anchor groups. We also presented estimates from COI of -4 for Stiffness, Function, and Gait and -3 for quality of life. These estimates can be used for research and patient monitoring.

Adaptation of the One Health Zoonotic Disease Prioritization Tool for Government and Privately Owned Companion Animal Zoonotic Disease Surveillance

The U.S. Army Veterinary Services (AVS) provides public health guidance, consultation, and clinical support regarding zoonoses for the Department of Defense (DoD). AVS One Health Division was tasked with developing a surveillance tool for zoonoses of companion animals presenting to DoD veterinary facilities. Such a tool could help monitor the spread of zoonoses between U.S. military Service Members, their family members, and their pets. The primary objective was to prioritize zoonoses of interest for companion animal disease surveillance in the DoD. AVS implemented a semi-quantitative One Health approach to prioritize zoonoses of interest. The prioritization process followed five steps: (1) generate list of zoonoses to be ranked that are applicable to a DoD companion animal disease surveillance system, (2) develop criteria to identify the importance of a zoonoses, (3) develop criteria definition questions, (4) rank criteria, and (5) rank zoonoses. The prioritization process resulted in a ranked list of 14 zoonoses of interest which was presented to AVS leadership with three potential courses of action. Twelve zoonoses were selected for inclusion in DoD Companion Animal Disease Surveillance. The prioritized list of diseases was the first step in developing a DoD companion animal disease surveillance effort. Mirroring such an approach in civilian companion animal populations could fill a critical public health gap.

Stem Cell Therapy for Aging Related Diseases and Joint Diseases in Companion Animals.

Stem cell therapy is an attractive treatment for diseases in companion animals that cannot be treated by conventional veterinary medicine practices. The unique properties of stem cells, particularly the ability to differentiate into specific cell types, makes them a focal point in regenerative medicine treatments. Stem cell transplantation, especially using mesenchymal stem cells, has been proposed as a means to treat a wide range of injuries and ailments, resulting in tissue regeneration or repair. This review aims to summarize the veterinary use of stem cells for treating age-related and joint diseases, which are common conditions in pets. While additional research is necessary and certain limitations exist, the potential of stem cell therapy for companion animals is immense.

Case report on successful treatment for brain abscess in a Japanese monkey (Macaca fuscata)

BackgroundA brain abscess in human beings is a focal infection of the central nervous system frequently characterized by areas of localized cerebritis and central necrosis surrounded by a well vascularized capsule. A brain abscess, although sporadically reported, is relatively rare disease in domestic animals (horses, cattle, goats and alpacas), companion animals (dogs and cats) and laboratory nonhuman primates. Brain abscesses are life threatening disease that needs early and aggressive veterinary therapy.Case presentationThe purpose of this study on a brain abscess in a Japanese monkey was to report the investigational and therapeutic processes including clinical observations, hematological and serum biochemical profiles, and magnetic resonance imaging (MRI) features, probiotic and antibiotic therapy. In clinical observation, the monkey presented with slowly progressive gentle and depressed behavioral change. Hematological findings showed that slightly declined platelet counts gradually increased in the course of the treatment. Serum biochemical profiles revealed initial markedly elevated. A series of chemotherapy provide prominent relief from the influence of the brain abscess. MRI images illustrated that a brain abscess was located in the right frontal lobe and the mass was delineated by a thick rim, indicating the capsule formation stage. The lesion chronologically decreased in size over the course of treatment. Until 11 weeks after treatment of the brain abscess, the size of brain abscess continued to reduce, leaving an organized lesion trace. To the best of my knowledge, this is the first report on successful treatment for a brain abscess in a Japanese monkey (Macaca fuscata).ConclusionsMedical management of simian brain abscesses is possible based on the controlled and resolving nature of the lesions as determined by MRI and completion of a of chemical antibiotic treatment presented in this study.

반려동물을 위한 IoT 기반 이동식 캐리어 디자인과 위치추적장치 개발

As the society developed into a highly industrialized society, familyization of companion animals was promoted, and the basic growth of related industries such as feed, beauty, and pharmaceuticals developed. Recently, wired and wireless communication technology based on sensors, semiconductors, and IoT is also being applied to the location tracking of companion animals that are active outdoors. In particular, various studies are being conducted on theft, accident, location tracking and advance warning of accidents when the blind, disabled, or the elderly are outdoors with companion animals. Therefore, as artificial intelligence (AI) technologies that can comprehensively analyze and determine a large amount of information required between companion animals and humans are applied, so-called ‘pet-tech’ is attracting attention. In monitoring and analysis based on sensor data and momentum, a service centered on the behavior, emotion, and situational awareness of companion animals is provided to consumers, and it is a technology that enables consulting and connection services on the behavior, situation, disease, and abnormal behavior of companion animals. development is gradually increasing. These technical studies related to companion animals lead to the cross-section of animals that accompany humans and become humanized, but on the contrary, it is a case that proves that psychological panic is growing in urbanized human life such as human alienation and loneliness. do. In addition, due to the sharing of space, a product design that can manage cleanliness, hygiene, and health is required, and a planar heating element using nano-carbon is applied as a basic material for antibacterial and odor removal. Nanocarbon is a material that maintains human health, and has been used for a long time because of its excellent life-sustaining power and resilience, such as deodorization, antibacterial action, air purification, early cell activation, pain relief, dehumidification effect, and deep sleep purification. It is also used as a material. In this study, we propose “a mobile carrier and location tracking device based on a planar heating element and IoT for cleanliness, hygiene, and health management where pets and owners coexist”. It tests its performance by supporting a platform that can converge with IoT and track location through product design.